Our core strength lies in our research and development capabilities in the field of transdermal delivery.

Futura’s unique technology, expertise and know how, enables targeted and rapid delivery of clinically proven effective pharmaceutical treatments through the skin to the required site of action. 

Our versatile transdermal technology DermaSys® is tailored for each product to suit the specific therapeutic indication and desired speed of onset and duraction of action offering improvements over existing products or creating novel indications with compelling commercial potential. This means that our products are highly differentiated in their markets whilst avoiding the risks normally associated with the development of new molecules.

DermaSys® - Our unique patented transdermal technology platform

DermaSys® provides rapid and targeted local delivery clinically effective ingredients at therapeutic levels to the required site of action. DermaSys® is a versatile clear, odourless gel uniquely formulated using volatile solvent component formulations tailored for each product, to suit the specific therapeutic indication and desired speed of onset and duration of action. Each product is formulated to maximise its benefits for patients and consumers.

Such targeted delivery offers an optimised profile in terms of dose, onset time and duration of effect as well as an improved safety profile reducing the risk of side effects due to a lower systemic uptake.

Application of gel

Unique combination of solvents including volatile solvents

Seconds later

Volatile solvents evaporate, leaving the remaining solvent supersaturated

The supersaturation powerfully drives the product through the tissue

Minutes later

The product penetrates the skin rapidly offering rapid penetration or sustained release

Strong IP

DermaSys® is a proprietary transdermal technology platform with very strong IP offering a high level of product differentiation compared to existing marketed treatments.